Company intelligence / Profile preview

Raycan Technology

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Raycan has commercialized the world’s first all-digital radiation detection solution, with installations in hundreds of hospitals in China. Their digital PET/CT systems enable high-resolution medical imaging for early disease diagnosis, especially cancer. They have also developed security screening technologies and animal imaging solutions used internationally[2][3].

Therapeutic areas: OncologyOther
Modalities: Device
Industry: Medical Imaging

Partnerships

Huazhong University of Science and Technology (joint laboratory)NEUROMED/Morrissey Research Center for Digital PET

Beyond the preview

Go deeper on Raycan Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raycan Technology.

Explore the full profile